Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09786278.3Aexternal-prioritypatent/EP2344523B1/en
Application filed by Glaxosmithkline Biologicals S.A.filedCriticalGlaxosmithkline Biologicals S.A.
Publication of CY1117336T1publicationCriticalpatent/CY1117336T1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
Συνθέσεις οι οποίες είναι χρήσιμες για τη μείωση του κινδύνου, την πρόληψη και/ή τη θεραπευτική αγωγή μολύνσεων από S. Pyogenes (GAS), οι οποίες περιέχουν συνδυασμούς αντιγόνων GAS, μόρια νουκλεϊκών οξέων τα οποία κωδικοποιούν τα αντιγόνα ή αντισώματα τα οποία δεσμεύονται ειδικά προς τα αντιγόνα.Compositions useful for reducing the risk, prevention and / or treatment of S. pyogenes (GAS) infections, which contain combinations of GAS antigens, nucleic acid molecules that encode antigens or antibodies that specifically bind to the antigens.
CY20161100277T2008-09-172016-04-06
COGNITIVE VACCINES AND THERAPEUTICS AGAINST GAS
CY1117336T1
(en)